psychological health and a more acute onset of psychotic symptoms and functional impairment in the late teens and early twenties. However, it is yet unclear whether neuroanatomical data among individuals at clinical high risk (CHR) for psychosis can be modeled to detect early versus late neurodevelopmental influences that is predictive of future psychosis onset. Therefore, in this study, we investigated whether the timing of the appearance or course of the deviation from normal brain maturation, as determined using a machine learning algorithm trained on structural MRI data to estimate age, is potentially relevant to the early versus late neurodevelopmental framework among CHR individuals. Methods: A neuroanatomical-based age prediction model was trained using a supervised machine learning technique with T1 MRI scans from 953 typically developing healthy controls (HC) from the Pediatric Imaging, Neurocognition, and Genetics study (PING) study. The trained model was then applied to 109 HCs and 275 CHR, including 39 converters (CHR-C), from the North American Prodrome Longitudinal Study (NAPLS2) and 14 cases of first episode psychosis patients (FE) for external validation and clinical application. Discrepancy between neuroanatomical-based estimated age and chronological age was computed for each individual (i.e., brain age gap) and compared across clinical groups. Results: The PING-derived model for estimating age accurately predicted NAPLS HC subjects' chronological ages, explaining 51% of the variance (P < 0.001) in chronological age, with a mean absolute error of 1.41 years, providing evidence of independent external validation. CHR subjects and FE adolescents showed a significantly greater overestimated gap between model-predicted age and chronological age compared with HC (Ps < 0.01). This effect was significantly moderated by chronological age, with neuroanatomical-based estimated age systematically overestimating CHR cases aged 12-17 years, but not among those aged 18-21 years. In the ROC analysis, brain age gap was a significant predictor of conversion to psychosis with an area under the curve of 0.63 (P < 0.05) among younger adolescents. In addition, increased deviation of brain age gap predicted pattern of stably low functioning over time (P < 0.05) among CHR individuals. In contrast, previously reported evidence of an accelerated reduction in cortical thickness among CHR-C was found to apply only to those cases who were 18 years or older. Discussion: These results are consistent with the view that both early and later neurodevelopmental disturbances contribute to the onset and course of schizophrenia, with the two sets of influences having differing implications for the intercepts and trajectories in structural brain parameters as a function of age. The results also suggest that baseline neuroanatomical measures are likely to be useful in prediction of psychosis especially (or only) among CHR cases who are below 18 years of age at the time of ascertainment. Background: The dysbindin gene (DTNBP1) is located in chromosome 6p22.3, one of the regions of positive linkage for schizophrenia. In particular, dysbindin protein has been found to play a role in the glutatmate neural transmission in the brain. A strong genetic association between DTNBP1 and schizophrenia has been replicated through many recent studies. However, we have not replicated positive association between DTNBP1 and schizophrenia in our Korean sample. Because schizophrenia has been regarded as a disease with a quite heterogeneous origin and evolvement, it is useful to categorize patients with schizophrenia into relatively homogeneous subsets based on clinical characteristics including age at onset (AAO). We investigated the association between DTNBP1 and AAO of schizophrenia.
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S185. DTNBP1 IS ASSOCIATED WITH THE AGE AT ONSET OF KOREAN PATIENTS WITH

Methods:
We assessed age at first occurrence of positive psychotic symptoms of 197 patients with schizophrenia with DSM IV diagnosis, which was reevaluated by Korean version of Diagnostic Interview for Genetic Study. Five SNPs, SNPA, P1763, P1320, P1635 and P1655 of DTNBP1 were genotyped and genetic association analyses were performed using the PLINK program. Results: In SNPA, patients with AT (N=10) showed significant earlier AAO than those with AA (N=187) (p<0.0001). The patients with heterozygote for SNP P1763 (TG, N=40) or P1320 (CT, N=41) also showed significant earlier AAO than those with homozygote (P<0.0001, P<0.0001, respectively). In addition, haplotype of all SNPs (SNPA-P1320-P1635-P1655-P1763) analysis showed significant association with AAO (p=0.000953). Discussion: In conclusion, although we were unable to support an association between DTNBP1 and schizophrenia, DTNBP1 might play a role in disease modifying. However, considering the several limitations of this study, further research involving different polymorphisms in DTNBP1 and various clinical subsets with sufficient numbers will be required to evaluate the contribution of DTNBP1 to schizophrenia. Background: The rs3800779 polymorphism at KCNH2 gene, which encodes for a Voltage-Gated Potassium Channel Subunit, has been associated with the risk for schizophrenia (SZ) and with changes in the expression of a brain isoform with specific electrophysiological characteristics (Huffaker et al., 2009) . It has been hypothesized that the KCNH2 gene variability could be involved in SZ by means of modulating the neuronal excitability. Graph-theory parameters applied to electroencephalographic (EEG) activity are useful to assess functional connectivity in the brain and have shown altered patterns of global connectivity in schizophrenia. We aimed to investigate whether KCNH2 contributes to functional connectivity alterations replicated in SZ patients. Methods: EEG data were acquired during the performance of an odd-ball task in 50 schizophrenia patients and 101 matched healthy controls. The rs3800779 at KCNH2 was genotyped. From the EEG activity, the Small World index (SW, a measure of network efficiency) was calculated as the coefficient between clustering coefficient (CLC, a measure of network segregation) and path length (PL, a measure of network integration). SW was calculated in two temporal windows with respect to the target tone (pre-stimulus and response). Functional SW modulation (SWm) was calculated as the difference in SW between pre-stimulus and response windows. Finally, the association between KCNH2 polymorphism and functional connectivity modulation was assessed. Results: Patients carrying the A allele (AA or AC, n=25) showed smaller SW modulation in comparison with patients with the CC genotype (n=25) (t=-2.84, df=48, p=0.007). Moreover, patients carrying the A allele showed smaller SW modulation than healthy controls with the A allele (n=45) (t=-3.41, df=68, p=0.001) or without the A allele (n=56) (t=-3.87, df=79 p<0.001). There were no significant SW modulation differences between healthy controls carrying or not the A allele. Patients with the AA/AC genotype showed an inverse SW modulation pattern (decreased SW at response) in comparison with patients without the A allele and controls (increased SW at response). Discussion: Our data indicate that, within SZ patients, the A allele is associated with smaller SW modulation and lower SW values at response, which might be interpreted as an altered ability to coordinate the activity of neural assemblies during cognitive tasks (Basar et al 2016) . Although replication analyses are needed, our findings suggest that genetic variation at KCNH2 might contribute to the efficiency of brain functional networks in schizophrenia patients. References: 1. Basar, E., Golbasi, B.T., Tulay, E., Aydin, S., Basar-Eroglu, C., 2016. Best method for analysis of brain oscillations in healthy subjects and neuropsychiatric diseases. Int J Psychophysiol 103, 22-42. 2. \Huffaker, S.J., Chen, J., Nicodemus, K.K., Sambataro, F., Yang, F., Mattay, V., Lipska, B.K., Hyde, T.M., Song, J., Rujescu, D., Giegling, I., Mayilyan, K., Proust, M.J., Soghoyan, A., Caforio, G., Callicott, J.H., Bertolino, A., Meyer-Lindenberg, A., Chang, J., Ji, Y., Egan, M.F., Goldberg, T.E., Kleinman, J.E., Lu, B., Weinberger, D.R., 2009. A primatespecific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nature medicine 15 (5) Background: Genomic research has revealed that schizophrenia is a highly polygenic disease. Recent estimates indicate that at least 71% of genomic segments of 1 Mb include one or more risk loci for schizophrenia (Loh et al., Nature Genet 2015) . This extremely high polygenicity represents a challenge to decipher the biological basis of schizophrenia, as it is expected that any set of SNPs with enough size will be associated with the disorder. Among the different gene sets available for study (such as those from Gene Ontology, KEGG pathway, Reactome pathways or protein protein interaction datasets), those based on brain co-expression networks represent putative functional relationships in the relevant tissue. The aim of this work was to identify brain co-expression networks that contribute disproportionately to the common polygenic risk for schizophrenia to get more insight on schizophrenia etiopathology. Methods: We analyzed a case -control dataset consisting of 582 schizophrenia patients from Galicia, NW Spain, and 591 ancestrally matched controls, genotyped with the Illumina PsychArray. Using as discovery sample the summary results from the largest GWAS of schizophrenia to date (Psychiatric Genomics Consortium, SCZ2), we generated polygenic risk scores (PRS) in our sample based on SNPs located at genes belonging to brain co-expression modules determined by the CommonMind Consortium (Fromer et al., Nature Neurosci 2016). PRS were generated using the clumping procedure of PLINK, considering several different thresholds to select SNPs from the discovery sample. In order to test if any specific module increased risk to schizophrenia more than expected by their size, we generated up to 10,000 random permutations of the same number of SNPs, matched by frequency, distance to nearest gene, number of SNPs in LD and gene density, using SNPsnap. Results: As expected, most modules with enough number of independent SNPs belonging to them showed a significant increase in Nagelkerke's R2 in our case-control sample after the addition of the module-specific PRS in a logistic regression model. Our permutation strategy revealed that most modules did not show an excess of risk, measured by increase in Nagelkerke's R2, in comparison to equal number of SNPs with similar characteristics. But one module, M2c from Fromer et al., remained highly significant after multiple tests' correction. Reactome pathways analysis revealed an over-representation of genes involved in "Neuronal System" and "Axon guidance" among
